P591: PRELIMINARY RESULTS OF A PHASE I STUDY OF CLIFUTINIB, A HIGHLY SELECTIVE, POTENT ORAL FLT-3 INHIBITOR, IN PATINETS WITH FLT3-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

Bibliographic Details
Main Authors:	W. Yu, X. Wei, Z. Ge, Y. Li, Z. Jiang, L. Yang, L. Lin, Y. Yao, X. Deng, X. Du, T. Chen, X. Feng, J. Zhou, M. Hou, R. Fu, J. Lan, X. Hu, S. Huang, J. Wang, H. Yang, H. Wang, L. Zheng, Z. Wang, B. Liu, N. Kang, Y. Zhuang, Y. Zhang, J. Jin
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000845252.68424.50

Internet